SCHEMBL633608

SCHEMBL633608

c1ccc(Oc2cccc3c2-c2nc-3nc3[nH]c(nc4nc(nc5[nH]c(n2)c2cccc(Oc6ccccc6)c52)-c2cccc(Oc5ccccc5)c2-4)c2cccc(Oc4ccccc4)c32)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 6/20 0.34
▸ EGLN1 Q9GZT9 2/20 0.34
▸ F2 P00734 2/20 0.34
▸ F10 P00742 2/20 0.34
▸ PLG P00747 2/20 0.34
▸ PLAU P00749 2/20 0.34
▸ PLAT P00750 2/20 0.34
▸ MMP13 P45452 1/20 0.33
▸ ELANE P08246 1/20 0.33
▸ LMNA P02545 3/20 0.32
▸ MAPT P10636 3/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ HTT P42858 2/20 0.32
▸ NPSR1 Q6W5P4 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3136757 0.98 BRD4 (0.33) BRD4EGLN1F2F10PLG
SCHEMBL9360821 0.93 BRD4 (0.33) BRD4EGLN1F2F10PLG
SCHEMBL7131959 0.91 BRD4 (0.36) BRD4EGLN1F2F10PLG
SCHEMBL9360081 0.87 MMP13 (0.36) BRD4EGLN1MMP13LMNAKMT2A
SCHEMBL785277 0.87 LMNA (0.33) LMNAMAPTKMT2AHTTNPSR1
SCHEMBL9438281 0.85 MEN1 (0.34) EGLN1MMP13KMT2AMEN1TDP1
SCHEMBL9360833 0.85 RORC (0.32) —
SCHEMBL5972535 0.83 MEN1 (0.36) LMNAMAPTKMT2AHTTNPSR1
SCHEMBL9359791 0.82 CDK1 (0.32) EGLN1F2F10PLGPLAU
SCHEMBL27279407 0.81 MEN1 (0.35) LMNAMAPTKMT2AHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431051-B2 Organic polymeric photon up-conversion nanoparticles for biological applications SONY CORPORATION (JP) 2013-04-30 — — US claimed
US-8419985-B2 Polymeric nanoparticles comprising a medium for photon up-conversion SONY CORPORATION (JP) 2013-04-16 — — US claimed
EP-2075304-B1 A DEVICE FOR MODIFYING THE WAVELENGHT RANGE OF A SPECTRUM OF LIGHT SONY CORP (JP) 2018-02-21 — — EP disclosed
US-8597715-B2 Target activated microtransfer THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2013-12-03 — — US disclosed
US-8574465-B2 Organic polymeric photon up-conversion nanoparticles for biological applications SONY CORPORATION (JP) 2013-11-05 — — US disclosed
US-20130236555-A1 ORGANIC POLYMERIC PHOTON UP-CONVERSION NANOPARTICLES FOR BIOLOGICAL APPLICATIONS SONY CORPORATION (JP) 2013-09-12 — — US disclosed
US-8460744-B2 Target activated microtransfer THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2013-06-11 — — US disclosed
US-8431051-B2 Organic polymeric photon up-conversion nanoparticles for biological applications SONY CORPORATION (JP) 2013-04-30 — — US disclosed
US-8419985-B2 Polymeric nanoparticles comprising a medium for photon up-conversion SONY CORPORATION (JP) 2013-04-16 — — US disclosed
US-8400707-B2 Medium for photon energy up-conversion SONY CORPORATION (JP) 2013-03-19 — — US disclosed
EP-2298849-B1 Polymeric nanoparticles comprising a medium for photon up-conversion SONY CORP (JP) 2012-08-29 — — EP disclosed
EP-2075304-A1 A device for modifying the wavelenght range of a spectrum of light Sony Corporation (JP) 2009-07-01 — — EP disclosed
US-20060172278-A1 Target activated microtransfer THE GOV'T OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH & HUMAN SERVICES 2006-08-03 — — US disclosed
US-6867038-B2 Isolation of cellular material under microscopic visualization THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2005-03-15 — — US disclosed
EP-0991929-B1 CONVEX GEOMETRY ADHESIVE FILM SYSTEM FOR LASER CAPTURE MICRODISSECTION US GOV HEALTH & HUMAN SERV (US) 2003-03-26 — — EP disclosed
US-5346670-A Phthalocyanine and tetrabenztriazaporphyrin reagents BRITISH TECHNOLOGY GROUP U.S.A. INC. (US) 1994-09-13 — — US disclosed
EP-0434727-A4 RED-SHIFTED PHTHALOCYANINE AND TETRABENZTRIAZAPORPHYRIN REAGENTS ULTRA DIAGNOSTIC CORP (US) 1994-08-17 — — EP disclosed
US-5135717-A Imaging therapy BRITISH TECHNOLOGY GROUP USA INC. (US) 1992-08-04 — — US disclosed
EP-0434727-A1 RED-SHIFTED PHTHALOCYANINE AND TETRABENZTRIAZAPORPHYRIN REAGENTS BRITISH TECHNOLOGY GROUP (USA) INCORPORATED (US) 1991-07-03 — — EP disclosed
WO-1990002747-A1 RED-SHIFTED PHTHALOCYANINE AND TETRABENZTRIAZAPORPHYRIN REAGENTS ULTRA DIAGNOSTICS CORPORATION (US) 1990-03-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130236555-A1 ORGANIC POLYMERIC PHOTON UP-CONVERSION NANOPARTICLES FOR BIOLOGICAL APPLICATIONS UPP1, MKI67, PPOX BRD4 2942/4885EGLN1 2842/4885F2 2796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback